alcoholic cirrhosis with esophageal varix bleeding相关文献:
Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions.
Liu YB, Chen MK.
World J Gastroenterol. 2022 Nov 7;28(41):5910-5930. doi: 10.3748/wjg.v28.i41.5910.
PMID:36405106
Outcome of individuals with alcoholic cirrhosis hospitalized with first decompensation and their predictors.
Giri S, Ingawale S, Harindanath S, Jain M, Garg P, Darak H, Kumar S, Kale A, Shukla A.
Indian J Med Res. 2024 Feb 1;159(2):213-222. doi: 10.4103/ijmr.ijmr_1690_22. Epub 2024 Apr 4.
PMID:38577860
Long-term outcomes of patients with cirrhosis presenting with bleeding gastric varices.
Nakazawa M, Imai Y, Sugawara K, Uchida Y, Saitoh Y, Fujii Y, Uchiya H, Ando S, Nakayama N, Tomiya T, Mochida S.
PLoS One. 2022 Mar 15;17(3):e0264359. doi: 10.1371/journal.pone.0264359. eCollection 2022.
PMID:35290384
Bleeding risk in patients with esophageal varices undergoing transesophageal echocardiography.
Pantham G, Waghray N, Einstadter D, Finkelhor RS, Mullen KD.
Echocardiography. 2013 Nov;30(10):1152-5. doi: 10.1111/echo.12274. Epub 2013 Jun 6.
PMID:23742625
Sclerotherapy of esophageal varices in hemophilia patients with liver cirrhosis - a prospective, controlled clinical study.
Szczepanik AB, Pielaciński K, Oses-Szczepanik AM, Huszcza S, Misiak A, Dąbrowski WP, Gajda S.
Pol Przegl Chir. 2018 Feb 28;90(1):29-34. doi: 10.5604/01.3001.0011.5957.
PMID:29513248
Helicobacter pylori versus platelet-to-spleen ratio as a risk factor for variceal bleeding in patients with liver-cirrhosis-related portal hypertension.
Metwally K, Essam T, Atwa A, Awad S, Abdelsameea E.
Am J Med Sci. 2022 Jul;364(1):23-28. doi: 10.1016/j.amjms.2021.10.018. Epub 2022 Jan 2.
PMID:34986362
Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis.
Huang DQ, Tan DJH, Ng CH, Amangurbanova M, Sutter N, Lin Tay PW, Lim WH, Yong JN, Tang A, Syn N, Muthiah MD, Tan EXX, Dave S, Tay B, Majzoub AM, Gerberi D, Kim BK, Loomba R.